




The US approved tenofovir for HIV treatment in 2001. It was only approved in South Africa in 2005, despite South Africa’s far larger burden of disease. The African Medicines Agency is attempting to reduce these delays. @EnlliMcA explains both the promises and pitfalls in @indevmag: indevelopmentmag.substack.com/p/can-africa-r…












